Exact Mass: 583.2546
Exact Mass Matches: 583.2546
Found 140 metabolites which its exact mass value is equals to given mass value 583.2546
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Brigatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Cys Ile Trp Tyr
Cys Ile Tyr Trp
Cys Leu Trp Tyr
Cys Leu Tyr Trp
Cys Trp Ile Tyr
Cys Trp Leu Tyr
Cys Trp Tyr Ile
Cys Trp Tyr Leu
Cys Tyr Ile Trp
Cys Tyr Leu Trp
Cys Tyr Trp Ile
Cys Tyr Trp Leu
Phe Met Met Arg
Phe Met Arg Met
Phe Met Thr Trp
Phe Met Trp Thr
Phe Arg Met Met
Phe Thr Met Trp
Phe Thr Trp Met
Phe Trp Met Thr
Phe Trp Thr Met
His His Gln Tyr
His His Tyr Gln
His Asn Gln Trp
His Asn Trp Gln
His Gln His Tyr
His Gln Asn Trp
His Gln Trp Asn
His Gln Tyr His
His Trp Asn Gln
His Trp Gln Asn
His Tyr His Gln
His Tyr Gln His
Ile Cys Trp Tyr
Ile Cys Tyr Trp
Ile Trp Cys Tyr
Ile Trp Tyr Cys
Ile Tyr Cys Trp
Ile Tyr Trp Cys
Leu Cys Trp Tyr
Leu Cys Tyr Trp
Leu Trp Cys Tyr
Leu Trp Tyr Cys
Leu Tyr Cys Trp
Leu Tyr Trp Cys
Met Phe Met Arg
Met Phe Arg Met
Met Phe Thr Trp
Met Phe Trp Thr
Met Met Phe Arg
Met Met Arg Phe
Met Arg Phe Met
Met Arg Met Phe
Met Thr Phe Trp
Met Thr Trp Phe
Met Trp Phe Thr
Met Trp Thr Phe
Asn His Gln Trp
Asn His Trp Gln
Asn Gln His Trp
Asn Gln Trp His
Asn Trp His Gln
Asn Trp Gln His
Gln His His Tyr
Gln His Asn Trp
Gln His Trp Asn
Gln His Tyr His
Gln Asn His Trp
Gln Asn Trp His
Gln Trp His Asn
Gln Trp Asn His
Gln Tyr His His
Arg Phe Met Met
Arg Met Phe Met
Arg Met Met Phe
Thr Phe Met Trp
Thr Phe Trp Met
Thr Met Phe Trp
Thr Met Trp Phe
Thr Trp Phe Met
Thr Trp Met Phe
Trp Cys Ile Tyr
Trp Cys Leu Tyr
Trp Cys Tyr Ile
Trp Cys Tyr Leu
Trp Phe Met Thr
Trp Phe Thr Met
Trp His Asn Gln
Trp His Gln Asn
Trp Ile Cys Tyr
Trp Ile Tyr Cys
Trp Leu Cys Tyr
Trp Leu Tyr Cys
Trp Met Phe Thr
Trp Met Thr Phe
Trp Asn His Gln
Trp Asn Gln His
Trp Gln His Asn
Trp Gln Asn His
Trp Thr Phe Met
Trp Thr Met Phe
Trp Tyr Cys Ile
Trp Tyr Cys Leu
Trp Tyr Ile Cys
Trp Tyr Leu Cys
Tyr Cys Ile Trp
Tyr Cys Leu Trp
Tyr Cys Trp Ile
Tyr Cys Trp Leu
Tyr His His Gln
Tyr His Gln His
Tyr Ile Cys Trp
Tyr Ile Trp Cys
Tyr Leu Cys Trp
Tyr Leu Trp Cys
Tyr Gln His His
Tyr Trp Cys Ile
Tyr Trp Cys Leu
Tyr Trp Ile Cys
Tyr Trp Leu Cys
Brigatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-[(2R,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
2-[(2R,4aS,12aS)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(2S,4aS,12aR)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(2R,4aS,12aR)-8-[(4-chlorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-piperidin-1-ylethyl)acetamide
2-[(2S,4aR,12aS)-8-[(4-chlorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-piperidin-1-ylethyl)acetamide
2-[(2S,4aR,12aR)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
N-[(2R,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
2-[(2S,4aS,12aS)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(2R,4aR,12aR)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(2R,4aR,12aS)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.